Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|January 9, 2020
Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugsMuge Akbulut, Yuksel Urun
Future Oncology (London, England)|April 22, 2024
Accuracy and usability of artificial intelligence chatbot generated chemotherapy protocolsEfe Cem Erdat, Merih Yalciner, Yuksel Urun
Critical Reviews in Oncology/Hematology|April 30, 2024
Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysisSati Coskun Yazgan, Erman Akkus, Emre Yekeduz, et al.
Renal Failure|July 11, 2006
Performing only one cardiovascular reflex test has a high positive predictive value for diagnosing autonomic neuropathy in patients with chronic renal failure on hemodialysisMesut Sahin, Mansur Kayatas, Yuksel Urun, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 12, 2019
Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancerCigdem Soydal, Mine Araz, Yuksel Urun, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 11, 2018
Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancerCigdem Soydal, Yuksel Urun, Evren Suer, et al.
The Prostate|September 30, 2024
The prognostic role of pan-immune inflammation value in patients with metastatic castration resistance prostate cancer treated with Lutetium-177 (<sup>177</sup>Lu)-PSMA-617Satı Coskun Yazgan, Emre Yekeduz, Mine Araz, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 25, 2020
Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literatureHatime A Yaşar, Erman Akkus, Aylin Heper, et al.
Critical Reviews in Oncology/Hematology|December 5, 2017
ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysisYuksel Urun, Jeffrey J Leow, Andre P Fay, et al.
Nuclear Medicine Communications|October 1, 2019
18F-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic valueCigdem Soydal, Mine Araz, Yuksel Urun, et al.
Pageof 5